 |
answer text |
<p>The Cardiovascular Disease (CVD) prevention initiatives report summarises a wide
range of actions led by Public Health England (PHE) which will reduce preventable
deaths from CVD. This can be viewed at the following link:</p><p><a href="http://www.healthcheck.nhs.uk/commissioners-and-providers/national-guidance/"
target="_blank">www.healthcheck.nhs.uk/commissioners-and-providers/national-guidance/</a></p><p>In
February 2018 PHE published national ambitions on the secondary prevention of Atrial
Fibrillation, High Blood Pressure and High Cholesterol. This can be viewed at the
following link:</p><p><a href="https://publichealthmatters.blog.gov.uk/2019/02/14/health-matters-preventing-cardiovascular-disease/"
target="_blank">https://publichealthmatters.blog.gov.uk/2019/02/14/health-matters-preventing-cardiovascular-disease/</a></p><p>People
aged 40-74 without existing disease are eligible once every five years for an NHS
Health Check, England’s CVD prevention programme. Modelling shows that the programme,
is cost effective with potential savings to the National Health Service of around
£57 million per year after four years, rising to £176 million per year after 15 years.
This equates to a cost per Quality Adjusted Life Year of around £3,000, considerably
lower than the National Institute for Health and Care Excellence’s threshold. The
cost benefits of the programme primarily arise from the opportunity it presents to
prevent 1,600 heart attacks and strokes and save at least 650 lives each year. A copy
of the Economic Modelling for Vascular Checks is attached.</p><p>The United Kingdom
National Screening Committee has not undertaken an assessment of the impact of routine
screening for the elderly to prevent deaths due to heart disease. Therefore, the Committee
has not made a recommendation on this issue.</p>
|
|
